Factors Associated with High-Dose Corticosteroid Use in SLE Patients Post Initiation of SLE Therapy

被引：0
|
作者：
Schroeder, Krista [1 ]
Gelwicks, Steve [1 ]
Paik, Jim [2 ]
Hoffman, Robert W. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, HEOR, Indianapolis, IN 46285 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
291
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PERFORATION OF THE COLON IN HIGH-DOSE CORTICOSTEROID-THERAPY OF PEMPHIGUS
    WEBB, PK
    CONANT, MA
    MAIBACH, HI
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1982, 6 (06) : 1040 - 1041
  • [32] Efficacy of Low-Dose Corticosteroid Therapy Versus High-Dose Corticosteroid Therapy in Bell's Palsy in Children
    Arican, Pinar
    Dundar, Nihal Olgac
    Gencpinar, Pinar
    Cavusoglu, Dilek
    JOURNAL OF CHILD NEUROLOGY, 2017, 32 (01) : 72 - 75
  • [33] Use of high-dose intravenous corticosteroid treatment in a child with scleredema
    Kurtoglu, S
    Yüksel, S
    Gündüz, Z
    Per, H
    Narin, N
    Kontas, O
    Özdemir, MA
    Çaksen, H
    JOURNAL OF EMERGENCY MEDICINE, 2004, 26 (02): : 245 - 246
  • [34] Factors associated with coronary artery calcification in young female patients with SLE
    Manger, K
    Kusus, M
    Forster, C
    Ropers, D
    Daniel, WG
    Kalden, JR
    Achenbach, S
    Manger, B
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (09) : 846 - 850
  • [35] Infrequent ovarian failure in SLE patients using low dose cyclophosphamide therapy
    Blatyta, P
    Appenzeller, S
    Costallat, LT
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 212 - 212
  • [36] Eliciting Systemic Lupus Erythematosus (SLE) patients' benefit-risks preferences for corticosteroid use
    Ng, Xinyi
    Fitz-Randolph, Marcy
    Beardsley, Robert
    Magder, Laurence
    Mullins, C. Daniel
    dosReis, Susan
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 33 - 34
  • [37] Durable complete remissions following high-dose cyclophosphamide for refractory systemic lupus erythematosus (SLE).
    Brodsky, RA
    Petri, M
    Smith, BD
    Jones, RJ
    BLOOD, 2000, 96 (11) : 422A - 422A
  • [38] TREATMENT OF HEMOLYTIC-ANEMIA AND SEVERE THROMBOCYTOPENIA WITH HIGH-DOSE METHYLPREDNISOLONE AND INTRAVENOUS IMMUNOGLOBULINS IN SLE
    ROLDAN, R
    ROMAN, J
    LOPEZ, D
    GONZALEZ, J
    SANCHEZ, C
    MARTINEZ, F
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (04) : 218 - 219
  • [39] GREATER SOCIAL VULNERABILITY ASSOCIATED WITH GREATER GLUCOCORTICOID USE IN PATIENTS WITH SLE
    Som, A.
    Mcmorrow, L.
    Chen, L.
    Sen, D.
    El-Qunni, A.
    Baker, E.
    Kim, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1509 - 1509
  • [40] EFFICACY OF A 6 WEEK DOUBLE-BLIND TRIAL OF HIGH-DOSE VS PULSE ORAL PREDNISOLONE THERAPY IN ACTIVE SLE
    MAHMOOD, T
    LINDSLEY, CB
    MARTINEZ, JD
    HASSANEIN, KF
    LINDSLEY, HB
    STECHSCHULTE, DJ
    ABDOU, NI
    CLINICAL RESEARCH, 1981, 29 (04): : A783 - A783
12345